Auto-reactive B cells against peripheral antigen, desmoglein 3, escape from tolerance mechanism

International Immunology

Volumn 16, Issue 10, 2004, Pages 1487-1495

  Ota, Takayuki ^a   Aoki Ota, Miyo ^a   Tsunoda, Kazuyuki ^a   Simoda, Kouji ^a   Nishikawa, Takeji ^a   Amagai, Masayuki ^a   Koyasu, Shigeo ^a,b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Autoimmunity; B1 B cell; Pemphigus vulgaris; Peripheral tolerance; Transgenic mouse

Indexed keywords

ANTIGEN; AUTOANTIGEN; DESMOGLEIN 3; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ANTIGEN DETECTION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE ACTIVATION; BLISTER; BULLOUS SKIN DISEASE; CELL SURFACE; CLINICAL OBSERVATION; CONTROLLED STUDY; FEMALE; IMMUNE SYSTEM; IMMUNOCOMPETENCE; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; KERATINOCYTE; LYMPH NODE; LYMPHOCYTE FUNCTION; MALE; MOUSE; NONHUMAN; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; SPLEEN; SQUAMOUS EPITHELIUM; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; AUTOANTIGENS; AUTOIMMUNITY; B-LYMPHOCYTES; CYTOSKELETAL PROTEINS; DESMOGLEIN 3; DESMOGLEINS; DESMOPLAKINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN M; IMMUNOGLOBULIN VARIABLE REGION; LYMPH NODES; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; SPLEEN;

EID: 5044252860     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh150     Document Type: Article

References (55)

1. Goodnow, C. C. 1996. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc. Natl Acad. Sci. USA 93:2264.
2. Nemazee, D. 2000. Receptor selection in B and T lymphocytes. Annu. Rev. Immunol. 18:19.
3. Nemazee, D. and Buerki, K. 1989. Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras. Proc. Natl Acad. Sci. USA 86:8039.
4. Nemazee, D. A. and Burki, K. 1989. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337:562.
5. Hartley, S. B., Crosbie, J., Brink, R., Kantor, A. B., Basten, A. and Goodnow, C. C. 1991. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 353:765.
6. Wang, H. and Shlomchik, M. J. 1997. High affinity rheumatoid factor transgenic B cells are eliminated in normal mice. J. Immunol. 159:1125.
7. Gay, D., Saunders, T., Camper, S. and Weigert, M. 1993. Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med. 177:999.
8. Tiegs, S. L., Russell, D. M. and Nemazee, D. 1993. Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 177:1009.
9. Radic, M. Z., Erikson, J., Litwin, S. and Weigert, M. 1993. B lymphocytes may escape tolerance by revising their antigen receptors. J. Exp. Med. 177:1165.
10. Prak, E. L., Trounstine, M., Huszar, D. and Weigert, M. 1994. Light chain editing in kappa-deficient animals: a potential mechanism of B cell tolerance. J. Exp. Med. 180:1805.
11. Chen, C., Radic, M. Z., Erikson, J., Camper, S. A., Litwin, S., Hardy, R. R. and Weigert, M. 1994. Deletion and editing of B cells that express antibodies to DNA. J. Immunol. 152:1970.
12. Goodnow, C. C., Crosbie, J., Adelstein, S. et al. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334:676.
13. Goodnow, C. C., Crosbie, J., Jorgensen, H., Brink, R. A. and Basten, A. 1989. Induction of self-tolerance in mature peripheral B lymphocytes. Nature 342:385.
14. Erikson, J., Radic, M. Z., Camper, S. A., Hardy, R. R., Carmack, C. and Weigert, M. 1991. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 349:331.
15. Offen, D., Spatz, L., Escowitz, H., Factor, S. and Diamond, B. 1992. Induction of tolerance to an IgG autoantibody. Proc. Natl Acad. Sci. USA 89:8332.
16. Shlomchik, M. J., Zharhary, D., Saunders, T., Camper, S. A. and Weigert, M. G. 1993. A rheumatoid factor transgenic mouse model of autoantibody regulation. Int. Immunol. 5:1329.
17. Scott, D. W. 1993. Analysis of B cell tolerance in vitro. Adv. Immunol. 54:393.
18. Hardy, R. R., Carmack, C. E., Li, Y. S. and Hayakawa, K. 1994. Distinctive developmental origins and specificities of murine CD5+ B cells. Immunol. Rev. 137:91.
19. Nisitani, S. and Honjo, T. 1999. Breakage of B cell tolerance and autoantibody production in anti-erythrocyte transgenic mice. Int. Rev. Immunol. 18:259.
20. Murakami, M., Tsubata, T., Okamoto, M., Shimizu, A., Kumagai, S., Imura, H. and Honjo, T. 1992. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature 357:77.
21. Hayakawa, K., Asano, M., Shinton, S. A., Gui, M., Allman, D., Stewart, C. L., Silver, J. and Hardy, R. R. 1999. Positive selection of natural autoreactive B cells. Science 285:113.
22. Hayakawa, K., Asano, M., Shinton, S. A., Gui, M., Wen, L. J., Dashoff, J. and Hardy, R. R. 2003. Positive selection of anti-thy-1 autoreactive B-1 cells and natural serum autoantibody production independent from bone marrow B cell development. J. Exp. Med. 197:87.
23. Rosado, M. M. and Freitas, A. A. 2000. B cell positive selection by self antigens and counter-selection of dual B cell receptor cells in the peripheral B cell pools. Eur. J. Immunol. 30:2181.
24. Watanabe, N., Ikuta, K., Nisitani, S., Chiba, T. and Honjo, T. 2002. Activation and differentiation of autoreactive B-1 cells by interleukin 10 induce autoimmune hemolytic anemia in Fas-deficient antierythrocyte immunoglobulin transgenic mice. J. Exp. Med. 196:141.
25. Russell, D. M., Dembic, Z., Morahan, G., Miller, J. F., Burki, K. and Nemazee, D. 1991. Peripheral deletion of self-reactive B cells. Nature 354:308.
26. Lang, J., Arnold, B., Hammerling, G., Harris, A. W., Korsmeyer, S., Russell, D., Strasser, A. and Nemazee, D. 1997. Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells. J. Exp. Med. 186:1513.
27. Pulendran, B., Kannourakis, G., Nouri, S., Smith, K. G. and Nossal, G. J. 1995. Soluble antigen can cause enhanced apoptosis of germinal-centre B cells. Nature 375:331.
28. Tighe, H., Heaphy, P., Baird, S., Weigle, W. O. and Carson, D. A. 1995. Human immunoglobulin (IgG) induced deletion of IgM rheumatoid factor B cells in transgenic mice. J. Exp. Med. 181:599.
29. Akkaraju, S., Canaan, K. and Goodnow, C. C. 1997. Self-reactive B cells are not eliminated or inactivated by autoantigen expressed on thyroid epithelial cells. J. Exp. Med. 186:2005.
30. Hartley, S. B. and Goodnow, C. C. 1994. Censoring of self-reactive B cells with a range of receptor affinities in transgenic mice expressing heavy chains for a lysozyme-specific antibody. Int. Immunol. 6:1417.
31. Lang, J., Jackson, M., Teyton, L., Brunmark, A., Kane, K. and Nemazee, D. 1996. B cells are exquisitely sensitive to central tolerance and receptor editing induced by ultralow affinity, membrane-bound antigen. J. Exp. Med. 184:1685.
32. Amagai, M., Klaus-Kovtun, V. and Stanley, J. R. 1991. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67:869.
33. Karpati, S., Amagai, M., Prussick, R., Cehrs, K. and Stanley, J. R. 1993. Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomes. J. Cell. Biol. 122:409.
34. Weigle, W. O. 1980. Analysis of autoimmunity through experimental models of thyroiditis and allergic encephalomyelitis. Adv. Immunol. 30:159.
35. Drachman, D. B. 1994. Myasthenia gravis. N. Engl. J. Med. 330:1797.
36. Richman, D. P., Agius, M. A., Kirvan, C. A., Gomez, C. M., Fairclough, R. H., Dupont, B. L. and Maselli, R. A. 1998. Antibody effector mechanisms in myasthenia gravis. The complement hypothesis. Ann. NY Acad. Sci. 841:450.
37. Amagai, M., Tsunoda, K., Suzuki, H., Nishifuji, K., Koyasu, S. and Nishikawa, T. 2000. Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus. J. Clin. Invest. 105:625.
38. Tsunoda, K., Ota, T., Suzuki, H., Ohyama, M., Nagai, T., Nishikawa, T., Amagai, M. and Koyasu, S. 2002. Pathogenic autoantibody production requires loss of tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris. Eur. J. Immunol. 32:627.
39. Tsunoda, K., Ota, T., Aoki, M., Yamada, T., Nagai, T., Nakagawa, T., Koyasu, S., Nishikawa, T. and Amagai, M. 2003. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J. Immunol. 170:2170.
40. Koch, P. J., Mahoney, M. G., Ishikawa, H., Pulkkinen, L., Uitto, J., Shultz, L., Murphy, G. F., Whitaker-Menezes, D. and Stanley, J. R. 1997. Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgans. J. Cell. Biol. 137:1091.
41. Matsuoka, K., Taya, C., Kubo, S., Toyama-Sorimachi, N., Kitamura, F., Ra, C., Yonekawa, H. and Karasuyama, H. 1999, Establishment of antigen-specific IgE transgenic mice to study pathological and immunobiological roles of IgE in vivo. Int. Immunol. 11:987.
42. Storb, U., Pinkert, C., Arp, B., Engler, P., Gollahon, K., Manz, J., Brady, W. and Brinster, R. L. 1986. Transgenic mice with mu and kappa genes encoding anti phosphorylcholine antibodies. J. Exp. Med. 164:627.
43. Hiramatsu, R., Akagi, K., Matsuoka, M. et al. 1995. The 3′ enhancer region determines the B/T specificity and pro-B/pre-B specificity of immunoglobulin V kappa-J kappa joining. Cell 83:1113.
44. Ishii, K., Amagai, M., Hall, R. P., Hashimoto, T., Takayanagi, A., Gamou, S., Shimizu, N. and Nishikawa, T. 1997. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J. Immunol. 159:2010.
45. Krebber, A., Bornhauser, S., Burmester, J., Honegger, A., Willuda, J., Bosshard, H. R. and Pluckthun, A. 1997. Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system. J. Immunol. Methods 201:35.
46. Hirose, S., Yan, K., Abe, M., Jiang, Y., Hamano, Y., Tsurui, H. and Shirai, T. 1997. Precursor B cells for autoantibody production in genomically Fas-intact autoimmune disease are not subject to Fas-mediated immune elimination. Proc. Natl Acad. Sci. USA 94:9291.
47. Kouskoff, V., Lacaud, G. and Nemazee, D. 2000. T cell-independent rescue of B lymphocytes from peripheral immune tolerance. Science 287:2501.
48. Hemmi, H., Yoshino, M., Yamazaki, H. et al. 2001. Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-beta 1-dependent cells. Int. Immunol. 13:695.
49. Shreedhar, V., Moodycliffe, A. M., Ullrich, S. E., Bucana, C., Kripke, M. L. and Flores-Romo, L. 1999. Dendritic cells require T cells for functional maturation in vivo. Immunity 11:625.
50. Bachmann, M. F., Rohrer, U. H., Kundig, T. M., Burki, K., Hengartner, H. and Zinkernagel, R. M. 1993. The influence of antigen organization on B cell responsiveness. Science 262:1448.
51. Anhalt, G. J., Martins, C., Rivitti, E. and Diaz, L. A. 1989. Endemic pemphigus foliaceus (Fogo Selvagem). Adv. Dermatol. 4:73.
52. Diaz, L. A., Sampaio, S. A., Rivitti, E. A. et al. 1989. Endemic pemphigus foliaceus (Fogo Selvagem): II. Current and historic epidemiologic studies. J. Invest. Dermatol. 92:4.
53. Warren, S. J., Lin, M. S., Giudice, G. J., Hoffmann, R. G., Hans-Filho, G., Aoki, V., Rivitti, E. A., Santos, V. and Diaz, L. A. 2000. The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil. Cooperative Group on Fogo Selvagem Research. N. Engl. J. Med. 343:23.
54. Ueki, H., Kohda, M., Nobutoh, T. et al. 2001. Antidesmoglein autoantibodies in silicosis patients with no bullous diseases. Dermatology 202:16.
55. Kabat, E. A., Wu, T. T. and Bilofsky, H. 1980. Evidence indicating independent assortment of framework and complementarity-determining segments of the variable regions of rabbit light chains. Delineation of a possible J minigene. J. Exp. Med. 152:72.